Works matching IS 11727047 AND DT 2022 AND VI 36 AND IP 5
1
- 2022
- Bradlow, Richard C. J.;
- Berk, Michael;
- Kalivas, Peter W.;
- Back, Sudie E.;
- Kanaan, Richard A.
- Correction Notice
3
- CNS Drugs, 2022, v. 36, n. 5, p. 411, doi. 10.1007/s40263-022-00918-0
- Article
4
- CNS Drugs, 2022, v. 36, n. 5, p. 517, doi. 10.1007/s40263-022-00917-1
- Gutiérrez‐Rojas, Luis;
- Sánchez-Alonso, Sergio;
- García Dorado, Marta;
- López Rengel, Paola M.
- Article
5
- CNS Drugs, 2022, v. 36, n. 5, p. 483, doi. 10.1007/s40263-022-00914-4
- Gurba, Katharine N.;
- Chaudhry, Rida;
- Haroutounian, Simon
- Article
6
- CNS Drugs, 2022, v. 36, n. 5, p. 419, doi. 10.1007/s40263-022-00913-5
- Wefel, Jeffrey S.;
- Ryan, Charles J.;
- Van, Julie;
- Jackson, James C.;
- Morgans, Alicia K.
- Article
7
- CNS Drugs, 2022, v. 36, n. 5, p. 541, doi. 10.1007/s40263-022-00912-6
- Article
8
- CNS Drugs, 2022, v. 36, n. 5, p. 529, doi. 10.1007/s40263-022-00908-2
- Heinonen, Essi;
- Forsberg, Lisa;
- Nörby, Ulrika;
- Wide, Katarina;
- Källén, Karin
- Article
9
- CNS Drugs, 2022, v. 36, n. 5, p. 451, doi. 10.1007/s40263-022-00907-3
- Bradlow, Richard C. J.;
- Berk, Michael;
- Kalivas, Peter W.;
- Back, Sudie E.;
- Kanaan, Richard A.
- Article